Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Neurobiol Aging. 2012 Sep 5;34(1):10.1016/j.neurobiolaging.2012.07.017. doi: 10.1016/j.neurobiolaging.2012.07.017

Table 1.

Case-control outcome adjusted for admixture (first 2 principal components) and center

SNP Chr Position
(Mb)
Gene Minor
allele
MAF
(case)
MAF
(control)
Joint p value Meta p value OR 95% CI
rs2303565 2q35 219.254 STK36 C 0.47 0.43 1.56E-06 (a) 6.18E-07 (a) 1.17 (1.10–1.24)
rs1344642 2q35 219.264 STK36 A 0.47 0.43 2.30E-06 (a) 9.92E-07 (a) 1.17 (1.10–1.25)
rs2814707 9p21.2 27.526 C9orf72a, MOBKL2Ba A 0.26 0.23 5.70E-07 (d) 8.39E-07 (d) 1.21 (1.11–1.33)
rs3849942 9p21.2 27.533 C9orf72a, MOBKL2Ba A 0.26 0.23 4.41E-07 (d) 6.47E-07 (d) 1.21 (1.11–1.33)
rs2453556 9p21.2 27.576 C9orf72a G 0.44 0.40 8.12E-07 (a) 6.95E-07 (a) 1.16 (1.09–1.24)
rs1971791 15q23 68.363 None within 150 kb G 0.49 0.47 9.70E-07 (r) 2.11E-06 (r) 1.26 (1.14–1.40)
rs8056742 16q24.1 83.650 KIAA0513 C 0.13 0.11 4.91E-07 (a) 2.94E-06 (d) 1.27 (1.14–1.41)
rs2109262 17p11.2 16.125 PIGL C 0.47 0.51 4.67E-07 (a) 4.12E-07 (d) 0.78 (0.71–0.87)
rs7477 17p11.2 16.187 CENPV T 0.52 0.48 2.89E-07 (r) 3.05E-07 (r) 1.30 (1.16–1.44)
rs2006933 17q11.2 23.625 FLJ40504a G 0.23 0.25 1.15E-06 (d) 8.60E-07 (d) 0.79 (0.73–0.86)
rs11082762 18q11.2 19.620 LAMA3 A 0.40 0.36 7.26E-07 (a) 1.78E-06 (a) 1.16 (1.09–1.24)
rs12608932 19p13.11 17.614 UNC13A C 0.38 0.34 1.29E-07 (a) 4.96E-08 (r) 1.37 (1.21–1.56)

SNPs are listed that have p < 1 × 10−6 in either the joint analysis or meta-analysis. For joint analysis, the additive model is presented unless the test for lack-of-fit to an additive model was significant (p < 0.05); (a) additive, (d) dominant, (r) recessive. For meta-analysis, the minimum p value of the 3 genetic models is used, noting that quality control standards were applied to ensure only appropriate samples sizes were included in the meta-analysis for each genetic model. There was no evidence for heterogeneity of the odds ratio across centers (p = 0.08, 0.09, and, > 0.20 for rs3849942, rs2814707, and remaining SNPs in the table, respectively). OR shown is from meta-analysis with 95% CI boundaries. Positions are from build 36.3.

Key: Chr, chromosome; CI, confidence interval; kb, kilobases; MAF, minor allele frequency; Mb, megabase; OR, odds ratio; SNP, single nucleotide polymorphism.

a

Less than 20 kb away.